PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 490.00
Ask: 491.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.204%)
Open: 485.00
High: 495.00
Low: 485.00
Prev. Close: 490.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Jan 2021 07:00

RNS Number : 5318M
Treatt PLC
22 January 2021
 

22 January 2021

TREATT PLC

("Treatt" or "the Group")

Trading update

Strong trading - profits expected to materially exceed market consensus

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today updates on trading since the start of its financial year ending 30 September 2021 ("FY21").

Highlights

· Strong operating performance across multiple categories and customers, with new organic revenue growth and enhanced margins from improving product mix.

· Profits for the first four months of the current financial year are expected to be ahead of Board's previous expectations for the period.

· Continued partnering with customers to develop exciting products in the fast-evolving beverages market is driving potential for further revenue and margin growth.

· Headwinds from COVID-19, the geopolitical landscape and commodity/currency risks remain.

· Overall, the Board is cautiously optimistic that the current strong momentum will result in profit before tax and exceptional items for FY21 materially exceeding the current market consensus* of £15.1m.

Trading performance

As reported in our FY20 results announcement on 24 November 2020, the Group had a strong start to the new financial year, and this has continued with the trading performance in the year to date being significantly better than expected.

The Group is performing particularly well in its citrus, health & wellness, fruit & vegetables and tea categories. Some material new business wins have been achieved including in the global alcoholic seltzer category which is continuing to grow strongly. Treatt is well positioned as a supplier of natural extracts including its sugar reduction solutions; the Group's technical expertise enables it to add significant value to customers across a growing range of applications resulting in margin expansion as well as revenue growth.

Whilst some parts of our product portfolio continue to be impacted from subdued on-trade demand due to the closure of venues in many parts of the World, this has been more than offset by increased demand from off-trade channels.

The Board considers that the strong trading momentum shown in these first few months of the current financial year will continue into H2 but is mindful that the Group faces the same uncertainties as our customers regarding the ongoing COVID-19 global pandemic, potential further lockdowns in our key markets and the volatile geopolitical landscape, with potential impacts on demand, FX rates and commodity prices. Nevertheless, the better than expected performance for the first four months of the year and the level of the order book leads the Board to be cautiously optimistic about continued growth in revenues, margins and profits for the rest of FY21, with profit before tax and exceptional items for FY21 expected to materially exceed current consensus* of £15.1m.

Daemmon Reeve, CEO, commented:

"We're encouraged by our strong trading momentum continuing into the current financial year. Performance has been positive across a number of our key categories, with particular growth in our solutions for the expanding alcoholic seltzer market, utilising our expertise in natural extracts.

"Whilst mindful of the global backdrop, we are confident that we can make further progress this year, to grow organic revenue across an increasingly global and diversified customer base who benefit from our technical expertise and value-add approach."

 

* Treatt compiled consensus of analyst forecasts for FY21 of profit before tax and exceptional items.

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Alex Wright

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

Information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLALLILFIL
Date   Source Headline
2nd Oct 20157:00 amRNSTrading Statement
29th Sep 20153:02 pmRNSTotal Voting Rights
2nd Sep 20152:19 pmRNSNotification of Transactions of Directors
27th Aug 201511:06 amRNSTotal Voting Rights
10th Aug 201511:44 amRNSDirector/PDMR Shareholding
21st Jul 20151:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20153:23 pmRNSDirector/PDMR Shareholding
10th Jun 20154:57 pmRNSDirector/PDMR Shareholding
4th Jun 20157:00 amRNSBlock Listing Six Monthly Return
1st Jun 201511:48 amRNSDirector/PDMR Shareholding
27th May 201512:07 pmRNSTotal Voting Rights
21st May 20155:11 pmRNSDirector/PDMR Shareholding
19th May 20157:00 amRNSHalf Yearly Report
14th Apr 20153:52 pmRNSDirector/PDMR Shareholding
8th Apr 20153:16 pmRNSDirector/PDMR Shareholding
30th Mar 20153:10 pmRNSDirector/PDMR Shareholding
30th Mar 20157:04 amRNSTrading Statement
23rd Mar 20153:15 pmRNSDirector/PDMR Shareholding
18th Mar 20154:59 pmRNSDirector/PDMR Shareholding
11th Feb 20154:19 pmRNSUpdate on Earthoil Earn-out Dispute
30th Jan 20154:09 pmRNSResult of AGM
14th Jan 20153:42 pmRNSDirector/PDMR Shareholding
8th Jan 201510:18 amRNSDirector/PDMR Shareholding
5th Jan 20153:26 pmRNSReplacement Director/PDMR Shareholding
5th Jan 201511:30 amRNSDirector/PDMR Shareholding
31st Dec 20147:00 amRNSAnnual Information Update
31st Dec 20147:00 amRNSTotal Voting Rights
16th Dec 20145:02 pmRNSDirector/PDMR Shareholding
12th Dec 20143:56 pmRNSAnnual Financial Report
9th Dec 20147:00 amRNSFinal Results
2nd Dec 20147:00 amRNSBlock Listing Application
28th Oct 20143:00 pmRNSVoting Rights and Capital
23rd Oct 20142:38 pmRNSDirector/PDMR Shareholding
7th Oct 20144:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20141:50 pmRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSTrading Statement
30th Sep 20144:02 pmRNSTotal Voting Rights
29th Sep 20144:25 pmRNSDirector/PDMR Shareholding
1st Sep 20149:22 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSTotal Voting Rights
1st Aug 20142:25 pmRNSDirector/PDMR Shareholding
29th Jul 201410:03 amRNSDirector/PDMR Shareholding
29th Jul 20147:00 amRNSInterim Management Statement
1st Jul 20143:44 pmRNSDirector/PDMR Shareholding
1st Jul 20148:32 amRNSDirector/PDMR Shareholding
30th Jun 20143:17 pmRNSHolding(s) in Company
23rd May 20144:39 pmRNSHolding(s) in Company
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.